CAM
Cidel Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.04M | Buy |
22,486
+666
| +3% | +$30.8K | 0.06% | 123 |
|
|
2025
Q1 | $1.33M | Buy |
21,820
+840
| +4% | +$51.2K | 0.09% | 100 |
|
|
2024
Q4 | $1.19M | Buy |
20,980
+1,133
| +6% | +$64.1K | 0.08% | 105 |
|
|
2024
Q3 | $1.03M | Buy |
19,847
+2,446
| +14% | +$127K | 0.07% | 115 |
|
|
2024
Q2 | $723K | Buy |
17,401
+3,250
| +23% | +$135K | 0.06% | 139 |
|
|
2024
Q1 | $767K | Buy |
14,151
+2,111
| +18% | +$114K | 0.06% | 136 |
|
|
2023
Q4 | $618K | Buy |
+12,040
| New | +$618K | 0.03% | 162 |
|
|
2019
Q3 | – | Sell |
-4,650
| Closed | -$211K | – | 122 |
|
|
2019
Q2 | $211K | Hold |
4,650
| – | – | 0.01% | 103 |
|
|
2019
Q1 | $222K | Buy |
+4,650
| New | +$222K | 0.01% | 121 |
|